Identification and early diagnosis for traditional Chinese medicine-induced liver injury based on translational toxicology

Zhongguo Zhongyao Zazhi

Volumn 39, Issue 1, 2014, Pages 5-9

  Wang, Jia Bo ^a   Xiao, Xiao He ^a   Du, Xiao Xi ^b   Zou, Zheng Sheng ^a   Song, Hai Bo ^b   Guo, Xiao Xin ^b  

^a 302 MILITARY HOSPITAL   (China)

^b Key lab of biological evaluation of medical devices of Shandong province   (China)

Author keywords

Biomarkers; Diagnosis; Hepatotoxicity; Traditional Chinese medicines; Translational toxicology

Indexed keywords

BIOLOGICAL MARKER; CHINESE DRUG;

ARTICLE; BIBLIOGRAPHIC DATABASE; CHINESE MEDICINE; CLINICAL CHEMISTRY; DRUG IDENTIFICATION; DRUG INDUCED DISEASE; DRUG INDUSTRY; DRUG RESEARCH; EARLY DIAGNOSIS; LABORATORY DIAGNOSIS; LIVER BIOPSY; LIVER INJURY; MEDICAL RECORD; SUSTAINABLE DEVELOPMENT; TOXICOLOGY; TRANSLATIONAL RESEARCH;

ANIMALS; BIOMARKERS, PHARMACOLOGICAL; BIOPSY; DRUG-INDUCED LIVER INJURY; EARLY DIAGNOSIS; HUMANS; LIVER; MEDICINE, CHINESE TRADITIONAL; RATS;

EID: 84895801581     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20140102     Document Type: Article

References (29)

1. Jung K A, Min H J, Yoo S S, et al. Drug-induced liver injury: twenty five cases of acute hepatitis following ingestion of Polygonum multiflorum Thunb[J]. Gut Liver, 2011, 5: 493.
2. Mattes W B, Walker E G. Translational toxicology and the work of the predictive safety testing consortium[J]. Clin Pharmacol Ther, 2009, 85(3): 327.
3. Danan G, Benichou C. Causality assessment of adverse drug reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries[J]. J Clin Epidemiol, 1993, 46: 1323.
4. Rockey D C, Seeff L B, Rochon J, et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclef causality assessment method[J]. Hepatology, 2010, 51(6): 2117.
5. Kleiner D E. The pathology of drug-induced liver injury[J]. Semin Liver Dis, 2009, 29: 364.
6. Lewis J H. Liver biopsy differentiates DILI from autoimmune hepatitis[J]. Nat Rev Gastroenterol Hepatol, 2011, 8: 540.
7. Suzuki A, Brunt E M, Kleiner D E, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury[J]. Hepatology, 2011, 54(3): 931.
8. Liss G, Rattan S, Lewis J H. Predicting and preventing acute drug-induced liver injury: what's new in 2010?[J]. Expert Opin Drug Metab Toxicol, 2010, 6: 1047.
9. Jeong T Y, Park B K, Cho J H, et al. A prospective study on the safety of herbal medicines, used alone or with conventional medicines[J]. J Ethnopharmcol, 2012, 143(3): 884.
10. Wang J B, Zhao H P, Xiao X H, et al. Hepatotoxicity or hepatoprotection pattern recognition for the paradoxical effect of the Chinese herb Rheum palmatum L. in treating rat liver injury[J]. PLoS ONE, 2011, 6(9): e24498.
11. But P P, Tomlinson B, Lee K L. Hepatitis related to the Chinese medicine Shou-wu-pian manufactured from Polygonum multiflorum[J]. Vet Human Toxicol, 1996, 38: 280.
12. Medicines and Healthcare Products Regulatory Agency. Polygonum multiflorum and liver reactions[EB/OL]. 2006-04-01. http://www.mhra.gov.uk/Safetyinformation/ Generalsafetyinformationandadvice/ Herbalmedicines/Herbalsafetyupdates/ Allherbalsafetyupdates/CON2023590.
13. Panis B, Wong D R, Hooymans P M, et al. Recurrent toxic hepatitis in a Caucasian girl related to the use of Shou Wu Pian, a Chinese herbal preparation[J]. J Pediatr Gastroenterol Nutr, 2005, 41: 256.
14. Hoofnagle J H, Serrano J, Knoben J E, et al. LiverTox: a website on drug-induced liver injury[J]. Hepatology, 2013, 57(3): 873.
15. National Toxicology Program. Technical report on the toxicology and carcinogenesis studies of emodin in F344/N rats and B6C3F1 mice[R]. Washington: Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC. 2001.
16. 2012, 26(5): 692.
17. 2012, 30(2): 123.
18. Lee M S, Jung B H, Chung B C, et al. Metabolomics study with gas chromatography-mass spectrometry for predicting valproic acid-induced hepatotoxicity and discovery of novel biomarkers in rat urine[J]. Int J Toxicol, 2009, 28(5): 392.
19. Amacher D E, Adler R, Herath A, et al. Use of proteomic methods to identify serum biomarkers associated with rat liver toxicity or hypertrophy[J]. Clin Chem, 2005, 51(10): 1796.
20. Antoine D J, Dear J W, Starkey-Lewis P, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital[J]. Hepatology, 2013, 58(2): 777.
21. Schomaker S, Warner R, Bock J, et al. Assessment of emerging biomarkers of liver injury in human subjects[J]. Toxicol Sci, 2013, 132(2): 276.
22. Bailey W J, Holder D, Patel H, et al. A performance evaluation of three drug-induced liver injury biomarkers in the rat: alpha-glutathione S-transferase, arginase 1, and 4-hydroxyphenyl-pyruvate dioxygenase[J]. Toxicol Sci, 2012, 130(2): 229.
23. Bell L N, Vuppalanchi R, Watkins P B, et al. Serum proteomic profiling in patients with drug-induced liver injury[J]. Aliment Pharmacol Ther, 2012, 35(5): 600.
24. Yaman H, Cakir E, Akgul E O, et al. Pentraxin 3 as a potential biomarker of acetaminophen-induced liver injury[J]. Exp Toxicol Pathol, 2013, 65(1/2): 147.
25. Cao Y, Wang H, Johnson T D, et al. Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging[J]. Int J Radiat Oncol Biol Phys, 2013, 85(1): 258.
26. Zhao F, Wang Y X, Yuan J, et al. MR T1ρ as an imaging biomarker for monitoring liver injury progression and regression: an experimental study in rats with carbon tetrachloride intoxication[J]. Eur Radiol, 2012, 22(8): 1709.
27. 2013, 6(1): 1.
28. 2012, 37(10): 1446.
29. 2012, 29(8): 692.